Dr. Rob Murphy is currently Professor of Medicine and Biomedical Engineering at Northwestern University where he is the John P. Phair Professor of Infectious Diseases and Director, Center for Global Health. He holds an academic appointment as Visiting Professor of Immunology and Infectious Diseases at the Harvard School of Public Health. Dr. Murphy’s primary research interest is in the diagnosis, treatment and management of human viral infections and their complications. His research includes development of new antiretroviral drugs, anti-hepatitis agents, and therapeutic vaccines. He has over 20 years of research and research training experience in sub-Saharan Africa primarily involving the scale up of therapy for HIV/AIDS, tuberculosis and malaria. His international activities and research interests include being Principal Investigator for the National Institutes for Health/Fogarty International Center’s AIDS International Training and Research Program based in Nigeria and Mali and the Medical Education Partnership Initiative in Nigeria. Dr. Murphy is the Principal Investigator for the National Institutes for Allergy and Infectious Diseases (NIAID) Adult AIDS Clinical Trials Group (ACTG) at Northwestern. Within the ACTG he holds leadership positions including membership on the Executive Committee, the governing body of the group, co-chair of the Data Management Committee and membership in the Hepatitis Transformative Science Group. He is the extramural Program Director for the Tuberculosis and Retrovirology Laboratories at SEREFO, University of Bamako, Mali. He is a member of multiple medical societies and sits on the boards of several non-profit organizations including the Drucker Family Charitable Trust, the International AIDS Education Project, Objectif Recherche Vaccin SIDA and the Midwest AIDS Foundation, of which he is the founder. He is a Senior Editor for the Journal of Antimicrobial Chemotherapy and has co-authored more than 255 scientific publications.